X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4291) 4291
Publication (480) 480
Book Chapter (67) 67
Newsletter (48) 48
Book Review (32) 32
Magazine Article (15) 15
Book / eBook (9) 9
Dissertation (7) 7
Conference Proceeding (6) 6
Reference (5) 5
Newspaper Article (2) 2
Data Set (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (2590) 2590
vasopressin (2203) 2203
male (1742) 1742
index medicus (1561) 1561
humans (1423) 1423
rats (1394) 1394
female (1035) 1035
physiology (835) 835
neurosciences (732) 732
endocrinology & metabolism (644) 644
mice (581) 581
oxytocin (540) 540
rats, sprague-dawley (515) 515
arginine-vasopressin (483) 483
research (463) 463
urology & nephrology (372) 372
arginine vasopressin - pharmacology (354) 354
receptors, vasopressin - genetics (352) 352
receptors, vasopressin - metabolism (352) 352
physiological aspects (350) 350
brain (330) 330
rats, wistar (330) 330
rodents (328) 328
pharmacology & pharmacy (326) 326
arginine vasopressin (323) 323
adult (321) 321
expression (318) 318
middle aged (310) 310
hormones, hormone substitutes, and hormone antagonists (305) 305
multidisciplinary sciences (291) 291
vasopressins - metabolism (284) 284
receptors (277) 277
research article (276) 276
vasopressins - pharmacology (271) 271
paraventricular nucleus (261) 261
receptor (260) 260
medicine (257) 257
gene expression (254) 254
hypothalamus (252) 252
biochemistry & molecular biology (251) 251
cells, cultured (243) 243
arginine vasopressin - metabolism (242) 242
immunohistochemistry (239) 239
neurons (236) 236
cell biology (234) 234
rat (229) 229
article (221) 221
dose-response relationship, drug (220) 220
aged (212) 212
stress (210) 210
cell line (209) 209
kidney (208) 208
analysis (206) 206
time factors (204) 204
calcium - metabolism (203) 203
blood pressure - drug effects (202) 202
antidiuretic hormone receptor antagonists (201) 201
messenger-rna (199) 199
science (196) 196
health aspects (195) 195
rna, messenger - metabolism (190) 190
molecular sequence data (186) 186
osmolar concentration (184) 184
mutation (183) 183
blood pressure (180) 180
cells (180) 180
secretion (180) 180
in vitro techniques (179) 179
hypertension (175) 175
angiotensin-ii (174) 174
endocrine system (174) 174
neurons - metabolism (174) 174
pituitary hormones (174) 174
collecting duct (172) 172
gene-expression (171) 171
mice, knockout (171) 171
nervous system (171) 171
kidney - metabolism (170) 170
mice, inbred c57bl (170) 170
proteins (169) 169
blood-pressure (168) 168
signal transduction (167) 167
aquaporin 2 (163) 163
corticotropin-releasing hormone (160) 160
phosphorylation (159) 159
vasopressins - physiology (159) 159
hyponatremia (157) 157
pregnancy (156) 156
hormones (155) 155
kidneys (153) 153
oxytocin - metabolism (153) 153
psychiatry (152) 152
behavior (151) 151
biology (150) 150
peripheral vascular disease (150) 150
social behavior (149) 149
amino acid sequence (148) 148
oxytocin - pharmacology (147) 147
genetic aspects (145) 145
sodium (145) 145
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4392) 4392
French (18) 18
Japanese (13) 13
Chinese (3) 3
Czech (2) 2
German (2) 2
Russian (2) 2
Bulgarian (1) 1
Danish (1) 1
Korean (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Physiology - Renal Physiology, ISSN 0363-6127, 2016, Volume 311, Issue 5, pp. F935 - F944
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2012, Volume 7, Issue 9, p. e45564
Journal Article
Peptides, ISSN 0196-9781, 04/2013, Volume 42, pp. 131 - 137
Journal Article
International Journal of Oncology, ISSN 1019-6439, 6/2015, Volume 46, Issue 6, pp. 2335 - 2345
Desmopressin (dDAVP) is a safe haemostatic agent with previously reported antitumour activity. It acts as a selective agonist for the V2 vasopressin membrane... 
[V4Q5]dDAVP | desmopressin analogue | metastases | breast carcinoma | vasopressin type 2 receptor | tumour vascularisation | Tumour vascularisation | [V 4 Q 5 ]dDAVP | Breast carcinoma | Desmopressin analogue | Vasopressin type 2 receptor | Metastases | PROTEIN-KINASE | MAMMARY-CARCINOMA | VON-WILLEBRAND-FACTOR | RESEARCH TOOLS | [VQ]dDAVP | PERIOPERATIVE DESMOPRESSIN | ONCOLOGY | CELL-MIGRATION | TREATMENT STRATEGIES | ENDOTHELIAL-CELLS | OXYTOCIN | CAMP | Humans | Deamino Arginine Vasopressin - analogs & derivatives | Receptors, Vasopressin - metabolism | Angiogenesis Inhibitors - pharmacology | Antineoplastic Agents - administration & dosage | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Xenograft Model Antitumor Assays | Deamino Arginine Vasopressin - administration & dosage | Angiogenesis Inhibitors - administration & dosage | Neoplasm Metastasis | Animals | MCF-7 Cells | Signal Transduction - drug effects | Cell Line, Tumor | Female | Antineoplastic Agents - pharmacology | Cell Proliferation - drug effects | Mice | Cell Cycle - drug effects | Deamino Arginine Vasopressin - pharmacology | Prevention | Desmopressin | Care and treatment | Desmopressin acetate | Breast cancer | Dosage and administration | Metastasis | Neovascularization | Angiogenesis | Toxicology | Cell growth | Chemotherapy | Peptides | Rodents | Ligands | Cancer therapies | Drug dosages | Tumors | Index Medicus
Journal Article
American Journal of Physiology - Renal Physiology, ISSN 1931-857X, 03/2013, Volume 304, Issue 5, pp. 553 - 564
Journal Article
Circulation: Heart Failure, ISSN 1941-3289, 07/2012, Volume 5, Issue 4, pp. 484 - 492
Background-Although recent clinical trials have demonstrated the efficacy of the oral vasopressin (AVP) type 2 receptor (V2R) antagonist tolvaptan, its... 
Heart failure | Myocardium | Kidney | Vasopressin type 2 receptor antagonist | heart failure | CARDIAC & CARDIOVASCULAR SYSTEMS | myocardium | ANGIOTENSIN-II | vasopressin type 2 receptor antagonist | TRANSITION | kidney | HYPERTROPHY | ARGININE-VASOPRESSIN | COLLECTING DUCT | LEFT-VENTRICULAR DYSFUNCTION | V-2-RECEPTOR ANTAGONIST | UP-REGULATION | EXPRESSION | Kidney - pathology | Heart Failure - physiopathology | Hypertension - drug therapy | Male | RNA, Messenger - metabolism | Kidney - metabolism | Time Factors | Myocardium - metabolism | Urination - drug effects | Rats, Inbred Dahl | Heart Failure - diagnostic imaging | Heart Failure - etiology | Disease Models, Animal | Kidney - drug effects | Administration, Oral | Kidney Diseases - pathology | Kidney Diseases - prevention & control | Ventricular Function, Left - drug effects | Rats | Heart Failure - metabolism | Biomarkers - blood | Sodium Chloride, Dietary | Disease Progression | Hormone Antagonists - administration & dosage | Ventricular Dysfunction, Left - diagnostic imaging | Heart Failure - drug therapy | Hypertension - metabolism | Ventricular Dysfunction, Left - metabolism | Receptors, Vasopressin - genetics | Hypertension - diagnostic imaging | Kidney Diseases - etiology | Antidiuretic Hormone Receptor Antagonists | Kidney Diseases - physiopathology | Biomarkers - urine | Receptors, Vasopressin - metabolism | Hypertension - etiology | Ultrasonography | Blood Pressure - drug effects | Kidney - physiopathology | Kidney Diseases - metabolism | Drug Administration Schedule | Ventricular Dysfunction, Left - etiology | Myocardium - pathology | Arginine Vasopressin - blood | Hypertension - physiopathology | Ventricular Dysfunction, Left - physiopathology | Ventricular Dysfunction, Left - prevention & control | Animals | Natriuretic Peptides - blood | Benzazepines - administration & dosage
Journal Article
Journal Article